- Pauwelsstraße 30, 52074 Aachen, Germany
- +49 (0) 241 80-89658
- international-office@ukaachen.de
Director
Prof. Dr. med. Tim H. Brümmendorf
Contact: Administrative Office, Marion Adrian
Phone: +49 (0)241 80-89805 / Fax: +49 (0)241 80-82449
madrian@ukaachen.de
Department of
Haematology, Oncology, Haemostaseology and
Stem Cell Transplantation
Internal Medicine IV
Medical Services
- Heart Surgery
- Treatment of blood diseases (anaemia, thrombocytopenia, leukaemia)
- High-dose chemotherapy and autologous stem cell transplantation
- Molecularly targeted therapy
- Bleeding disorders: assessment, prophylaxis and treatment of increased bleeding and thrombosis
- Treatment of malignant tumours (lymphoma, multiple myeloma, lung cancer, sarcoma)
- Specialised consultation (also in Turkish)
- Guiding the patient through the steps of complex multimodality cancer therapy
Research Focus
- Role of epigenetics in tumour development and treatment
- Biology of telomeres and stem cells in haematopoiesis
- Regulation of haematopoiesis
- Pathophysiology of myeloproliferative diseases
- Aplastic syndromes
- Principles of molecularly targeted treatment
Professor Brümmendorf has been head of the department since 2009. Additional he is the director of the Euregional comprehensive Cancer Centre Aachen (ECCA), where all oncological specialists of the hospital act closely together with the aim to offering the individually tailored best therapy to the cancer patient. Prior to Aachen, Professor Brümmendorf served as Deputy Medical Director of the Department of Haematology and Oncology at the University Hospital in Hamburg-Eppendorf, as well as Director of the University Cancer Centre Hamburg (UCCH). His main field of research is telomere biology in normal and increased haematopoiesis. His clinical academic focus is on myeloproliferative neoplasia (MPN), chronic myelogenous leukaemia (CML), aplastic syndromes and the treatment of head and neck tumours.
Internal Medicine IV is dedicated to treating all haematological diseases and malignant solid tumours. The focus is on the patient. Our aim is to provide the best possible care through interdisciplinary development of treatment strategies in accordance with the most current standards of knowledge. The department integrates supportive measures such as psycho-oncology.